Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH VanEck Vectors Pharmaceutical ETF

  • Fund Description

    VanEck Vectors Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 08/26/16

    • 30-Day SEC Yield1

      1.48%
    • Total Net Assets

      $275.1M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.36%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      09/30/2016
  • Portfolio Composition (%)
    as of 08/26/16

    • % of Net Assets
    • Stocks

      100.26
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.26
  • Download All HoldingsDaily Holdings (%) as of 08/26/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Merck & Co Inc
    MRK US
    240,134
    15,092,4225.49
    Abbvie Inc
    ABBV US
    224,144
    14,481,9445.26
    Johnson & Johnson
    JNJ US
    119,487
    14,223,7325.17
    Glaxosmithkline Plc
    GSK US
    325,490
    14,175,0905.15
    Astrazeneca Plc
    AZN US
    420,141
    13,885,6605.05
    Abbott Laboratories
    ABT US
    320,044
    13,755,4915.00
    Pfizer Inc
    PFE US
    392,531
    13,667,9294.97
    Novartis Ag
    NVS US
    170,003
    13,482,9384.90
    Allergan Plc
    AGN US
    55,355
    13,170,6154.79
    Zoetis Inc
    ZTS US
    257,028
    13,046,7414.74
    Eli Lilly & Co
    LLY US
    166,243
    13,006,8524.73
    Sanofi
    SNY US
    334,219
    12,964,3554.71
    Shire Plc
    SHPG US
    66,023
    12,589,2664.58
    Mckesson Corp
    MCK US
    66,328
    12,124,0954.41
    Teva Pharmaceutical Industries Ltd
    TEVA US
    230,652
    11,890,1114.32
    Amerisourcebergen Corp
    ABC US
    134,608
    11,542,6364.20
    Mylan Nv
    MYL US
    267,750
    11,521,2834.19
    Novo Nordisk A/S
    NVO US
    241,983
    11,346,5834.12
    Bristol-Myers Squibb Co
    BMY US
    188,486
    11,077,3224.03
    Perrigo Co Plc
    PRGO US
    106,930
    9,475,0673.44
    Valeant Pharmaceuticals International I
    VRX US
    222,965
    6,874,0112.50
    Mallinckrodt Plc
    MNK US
    56,653
    4,244,4431.54
    Jazz Pharmaceuticals Plc
    JAZZ US
    29,219
    3,755,2261.37
    Endo International Plc
    ENDP US
    121,255
    2,549,9930.93
    Akorn Inc
    AKRX US
    69,229
    1,859,4910.68
    Other/Cash
    --
    --
    -714,505-0.26
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.